This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Inflarx Gmbh. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Yong Li - Innovator in Pharmaceutical Modulation
Introduction
Yong Li is a prominent inventor based in Ann Arbor, MI (US), known for his contributions to pharmaceutical innovations. He holds two patents that focus on the modulation of the C5a receptor, which plays a significant role in various diseases.
Latest Patents
Yong Li's latest patents include "Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor." This invention relates to compounds that modulate the activities of the mammalian C5a receptor by directly binding to it. The patent also covers pharmaceutical compositions containing these compounds and their applications in treating diseases or disorders associated with pathogenic activation of C5a receptors.
Career Highlights
Yong Li is currently associated with Inflarx GmbH, where he continues to advance his research and development efforts in the pharmaceutical field. His work is pivotal in creating innovative solutions for health challenges.
Collaborations
Yong Li collaborates with notable colleagues, including Renfeng Guo and Niels Christoph Riedemann, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yong Li's work in modulating the C5a receptor through innovative compounds showcases his significant impact on pharmaceutical research. His contributions are vital for the development of new treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile